Katy Adams

Katy Adams

Presently: PhD student, Cardiff University School of Medicine under the supervision of Prof. Andy Sewell.

July 2000-Present: Senior Scientist at Immunocore Ltd (formerly Medigene Ltd and Avidex Ltd) Oxon. Key member of the cellular biology team with expertise in various cell assays and techniques for assessing T cell ImmTAC redirected activity.

April 2004-Oct 2004: T-cell Molecular Modulation Group (leader: Professor Andy Sewell), University of Oxford. A valuable and inspiring learning experience spent in an academic environment gaining knowledge in the generation and cloning of T cells to tumour antigens.

2001-2004: MSc Immunology, studied part-time. Awarded Distinction for project report. Research project: Isolation of T cells specific for Melanoma-Associated Antigen (MART-1). Involved the autologous stimulation of peripheral blood mononuclear cells (PBMCs) from healthy donors with MART-1 peptide. Analysis was performed using functional assays and flow cytometry. Clones were isolated by tetramer-directed FACS sorting. School of Applied Sciences, University of the West of England, Bristol.

May 1999-June 2000: Scientist, Immune Systems Ltd, Devon. Began as a Graduate Business Placement through Exeter University and I was kept on after the end of the placement as a full time scientist involved in the development of diagnostic tests, antibody production, antibody screening using ELISA assay as well as synthetic peptide production.

1995-1998: BSc (Hons) Biological Sciences – class 2i - University of Exeter.